Jankowski M, Angielski S, Szczepańska-Konkel M
Department of Monitoring Therapy and Pharmacogenetics, Medical University of Gdańsk, Poland.
J Physiol Pharmacol. 2008 Mar;59(1):129-37.
Previous studies from our laboratory have reported a marked reduction in glomerular filtration rate (GFR) and sodium reabsorption in renal proximal tubule during intravenous infusion of P(1),P(4)-diadenosine tetraphosphate (Ap(4)A) at dose of 1.0 micromol/kg + 10 nmol/kg/min (i.v., injection followed by infusion) in anaesthetized Wistar rats. In the present study, the changes of GFR and urine sodium excretion were investigated in response to systemic infusion of Ap(4)A at different doses. Ap(4)A at dose of 0.1 micromol/kg + 1.0 nmol/kg/min did not change GFR and sodium urinary excretion whereas 2-fold higher dose produced significant (3.4-fold) increase in sodium excretion without changes in GFR. Significant but transient reduction in GFR by approximately 21% was observed during infusion of Ap(4)A at dose of 0.5 micromol/kg + 5.0 nmol/kg/min. Higher doses of Ap(4)A (1.0 micromol/kg + 10 nmol/kg/min and 2.0 micromol/kg + 20 nmol/kg/min) reduction in GFR and marked natriuresis. Our results suggest that tubular sodium transport systems are more sensitive to Ap(4)A than systems involved in GFR regulation.
我们实验室之前的研究报告称,在麻醉的Wistar大鼠中,以1.0微摩尔/千克 + 10纳摩尔/千克/分钟的剂量静脉输注P(1),P(4)-二腺苷四磷酸(Ap(4)A)(静脉注射后持续输注)时,肾小球滤过率(GFR)和肾近端小管钠重吸收显著降低。在本研究中,研究了不同剂量的Ap(4)A全身输注后GFR和尿钠排泄的变化。0.1微摩尔/千克 + 1.0纳摩尔/千克/分钟剂量的Ap(4)A未改变GFR和尿钠排泄,而2倍高剂量则使钠排泄显著增加(3.4倍),GFR无变化。在输注0.5微摩尔/千克 + 5.0纳摩尔/千克/分钟剂量的Ap(4)A期间,观察到GFR显著但短暂降低约21%。更高剂量的Ap(4)A(1.0微摩尔/千克 + 10纳摩尔/千克/分钟和2.0微摩尔/千克 + 20纳摩尔/千克/分钟)使GFR降低并伴有明显的利钠作用。我们的结果表明,肾小管钠转运系统对Ap(4)A比参与GFR调节的系统更敏感。